Astana Biomed Group, an authorized Abcam distributor in Central Asia

Neurodegenerative disease

Human MAPK3 (ERK1) knockout A-431 cell line (ab276077)

Description:
MAPK3 KO A-431 cell line
Application:
Reactivity:
Conjugate:

Human MAPT knockout SHSY-5Y cell line (ab280077)

Description:
Human MAPT knockout SHSY-5Y cell line
Application:
Reactivity:
Conjugate:

Human MAPT knockout U-87 MG cell line (ab269490)

Description:
Human MAPT knockout U-87 MG cell line
Application:
Reactivity:
Conjugate:

Human PARK2 (Parkin) knockout SHSY-5Y cell line (ab280042)

Description:
Human PARK2 (Parkin) knockout SHSY-5Y cell line
Application:
Reactivity:
Conjugate:

Human PARK7 (DJ1) knockout U-87 MG cell line (ab280767)

Description:
Human PARK7 (DJ1) knockout U-87 MG cell line
Application:
Reactivity:
Conjugate:

Human PRKN knockout SH-SY5Y cell line (ab280873)

Description:
Human PRKN knockout SH-SY5Y cell line
Application:
Reactivity:
Conjugate:

Human SNCA (Alpha-synuclein) knockout U-87 MG cell line (ab280776)

Description:
Human SNCA (Alpha-synuclein) knockout U-87 MG cell line
Application:
Reactivity:
Conjugate:

Leflunomide, Immunomodulatory agent (ab141479)

Description:
Immunomodulatory agent
Application:
Reactivity:
Conjugate:

Leupeptin hemisulfate, serine/cysteine protease inhibitor (ab141404)

Description:
Reversible competitive serine/cysteine protease inhibitor
Application:
Reactivity:
Conjugate:

Limonin, Limonoid (ab141949)

Description:
Limonoid with antiviral activity
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.